Lynda Harper

First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial

Abdel Babiker, Hannah Castro, Alexandra Compagnucci et al. · The Lancet Infectious Diseases · 2011 · 132 citations · Full text

Protease Inhibitor, Treatment And Prevention, First-line Antiretroviral Therapy +7

Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1

Catherine Litalien, Albert Faye, Alexandra Compagnucci et al. · The Pediatric Infectious Disease Journal · 2003 · 36 citations

Response to planned treatment interruptions in HIV infection varies across childhood

Diana M. Gibb, Hannah Castro, Alexandra Compagnucci et al. · Zurich Open Repository and Archive (University of Zurich) · 2010 · 34 citations · Full text

Primary Immunodeficiency, Sexual Health, Chronic Hiv Infection +15

Comparative costs and activity from a sample of UK clinical trials units

Daniel Hind, Barnaby C Reeves, Sarah Bathers et al. · Trials · 2017 · 31 citations · Full text

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial

Anna Turkova, Cecilia L. Moore, Karina Butler et al. · PLoS ONE · 2018 · 27 citations · Full text